ICU Medical (NASDAQ:ICUI) Stock Rating Upgraded by StockNews.com

ICU Medical (NASDAQ:ICUI) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday.

Other analysts have also recently issued reports about the company. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Tuesday, April 8th. Raymond James set a $97.00 price target on ICU Medical in a research report on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, ICU Medical has an average rating of “Buy” and a consensus target price of $168.67.

ICU Medical Stock Performance

NASDAQ:ICUI opened at $138.67 on Wednesday. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm’s fifty day simple moving average is $146.73 and its 200 day simple moving average is $160.03. The stock has a market cap of $3.40 billion, a P/E ratio of -30.34 and a beta of 0.86. ICU Medical has a twelve month low of $93.36 and a twelve month high of $196.26.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Harvest Fund Management Co. Ltd purchased a new stake in shares of ICU Medical during the fourth quarter valued at approximately $33,000. Quarry LP lifted its position in ICU Medical by 764.3% in the 4th quarter. Quarry LP now owns 242 shares of the medical instruments supplier’s stock valued at $38,000 after acquiring an additional 214 shares in the last quarter. Murphy & Mullick Capital Management Corp purchased a new stake in ICU Medical during the 4th quarter valued at $52,000. Venturi Wealth Management LLC increased its holdings in shares of ICU Medical by 64.0% in the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier’s stock worth $82,000 after purchasing an additional 206 shares in the last quarter. Finally, Russell Investments Group Ltd. raised its stake in shares of ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier’s stock worth $99,000 after purchasing an additional 300 shares during the last quarter. 96.10% of the stock is owned by hedge funds and other institutional investors.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.